Search

Author/Creator Vera, I

1. DOP40 Comorbidities and epidemiological risk factor but not immunosuppressive therapies increase the risk of COVID-19 in Inflammatory Bowel Disease (IBD): An ENEIDA-based, case-control study. (27th May 2021)

Authors:
Zabana Abdo, Y; Marín-Jiménez, I; Rodríguez-Lago, I; Vera, I; Martín, M D; Guerra, I; Gisbert, J P; Mesonero, F; Benítez, O; Taxonera, C; Ponferrada-Díaz, Á; Piqueras, M; Lucendo, A; Caballol, B; Mañosa, M; Martínez-Montiel, P; Bosca-Watts, M; Gordillo, J; Bujanda, L; Manceñido, N
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S078
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P173 The deeper, the better: Histological activity defined as Nancy Index >2 predicted bad outcomes in patients with ulcerative colitis that achieved mucosal healing. (25th January 2019)

Authors:
Gonzalez-Partida, I; Gonzalez-Lama, Y; Gonzalez-Lois, C; Sanchez-Yuste, R; Salas, I; Suarez, C; Calvo, M; Matallana, V; Salas, C; Vera, I
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S175
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P290 Therapeutic requirements in patients with Ulcerative Proctitis. Is it necessary immunosuppressive therapy in these patients?. (21st January 2022)

Authors:
Ferreiro Iglesias, R; Porto Silva, M S; Marín, S; Casanova, M J; Mañosa, M; González-Muñoza, C; de Francisco, R; Caballol, B; Arias, L; Piqueras, M; Zabana, Y; Rivero, M; Calvet, X; Mesonero, F; Varela Trastoy, P; Busta Nistal, R; Gomez Perosanz, R; Vega, P; Gonzalez Vivo, M; Iborra, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i322
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P292 Association of golimumab trough concentrations during maintenance with endoscopic and histologic remission in patients with ulcerative colitis. (21st January 2022)

Authors:
Taxonera Samso, C; Fernández-Aceñero, M J; Olivares, D; Calvo, M; Casis, B; Bermejo, F; López Serrano, P; Iborra, M; Mesonero, F; Boscá Watts, M; Díaz del Arco, C; Vera, I; Olivares, S; Alba, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i323
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P355 Preferences and satisfaction of IBD patients in whom the adalimumab regimen was changed from 40 mg weekly to 80 mg every other week: the ADASCAL study. (27th May 2021)

Authors:
Taxonera Samso, C; Martínez-Montiel, P; Barreiro-De-Acosta, M; Vera, I; Lorente, R; Vega, P; Diz-Lois, M T; Fuentes Coronel, A M; Pérez Calle, J L; Casis, B; Ferreiro, R; Calvo, M; Olivares, D; Alba, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S374
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P437 Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry. (25th January 2019)

Authors:
Calafat, M; Mañosa, M; Panes, J; Nos, P; Iglesias, E; Vera, I; López-Sanromán, A; Guardiola, J; Taxonera, C; Mínguez, M; Martín, M D; de Castro, L; Riestra, S; Rivero, M; García-Planella, E; Calvet, X; García-López, S; Andreu, M; Gomollón, F; Barrio, J
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S328
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P443 Clinical features, therapeutic requirements, and evolution of patients with Crohn's disease and upper digestive tract involvement (CROHNEX study). (25th January 2019)

Authors:
Sainz Arnau, E; Zabana, Y; Miguel, I; Fernández Clotet, A; Casanova, M J; Martín, M D; Picó, M D; Alfambra, E; Rodriguez, I; Muñoz, F; Domínguez, M; Iglesias, E; Busquets, D; Gutiérrez, A; Cañete, F; Nuñez, L; Taxonera, C; Beltrán, B; Camps, B; Calvet, X
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S332
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P559 Real-life experience with long-term maintenance of golimumab in ulcerative colitis patients. (25th January 2019)

Authors:
Iborra, M; García-Morales, N; Rubio, S; Nantes Castillejo, O; Bertoletti, F; García-Planella, E; Calvo, M; Vera, I; Taxonera, C; Alba, C; Boscá-Watts, M; Martí-Aguado, D; Ballester Ferrer, M P; Sierra, M; Cano-Sanz, N; Mancenido, N; Pajares-Villarroya, R; Beltrán, B; Cañada, A; Nos, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S393
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P634 Ustekinumab and vedolizumab as first-line biological therapy for inflammatory bowel disease. A multicenter study based on the ENEIDA registry. (30th January 2023)

Authors:
Calafat Sard, M; Pascual, I; Nos, P; Barrio, J; Gutiérrez, A; Martín-Arranz, M D; Ricart, E; Gomollón, F; Sierra Ausín, M; Huguet, J M; Guardiola, J; Vera, I; Varela, P; Iglesias, E; Garcia-Planella, E; de Castro, L; García Sepulcre, M F; Sicilia, B; Fernández-Salazar, L; Calvet, X
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i766
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗